{"title":"SARS-Cov-2能否在特定感染人群中建立持续感染","authors":"Ikuta K","doi":"10.23880/vij-16000235","DOIUrl":null,"url":null,"abstract":"Novel coronavirus (SARS-CoV-2) is the causative agent for a new type of pneumonia (COVID-19) that firstly appeared in Wuhan, China, in December, 2019. The virus spread globally throughout the world within just three months next to its eruption, according to the Center for System Science and Engineering (CSSE), Johns Hopkins University, with nearly 2 million infected as of April 14, 2020, and nearly 120,000 deaths.","PeriodicalId":334586,"journal":{"name":"Virology & Immunology Journal","volume":"92 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Could SARS-Cov-2 Establish Persistent Infection in a Certain Population of Infected Individuals\",\"authors\":\"Ikuta K\",\"doi\":\"10.23880/vij-16000235\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Novel coronavirus (SARS-CoV-2) is the causative agent for a new type of pneumonia (COVID-19) that firstly appeared in Wuhan, China, in December, 2019. The virus spread globally throughout the world within just three months next to its eruption, according to the Center for System Science and Engineering (CSSE), Johns Hopkins University, with nearly 2 million infected as of April 14, 2020, and nearly 120,000 deaths.\",\"PeriodicalId\":334586,\"journal\":{\"name\":\"Virology & Immunology Journal\",\"volume\":\"92 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Virology & Immunology Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23880/vij-16000235\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virology & Immunology Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23880/vij-16000235","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Could SARS-Cov-2 Establish Persistent Infection in a Certain Population of Infected Individuals
Novel coronavirus (SARS-CoV-2) is the causative agent for a new type of pneumonia (COVID-19) that firstly appeared in Wuhan, China, in December, 2019. The virus spread globally throughout the world within just three months next to its eruption, according to the Center for System Science and Engineering (CSSE), Johns Hopkins University, with nearly 2 million infected as of April 14, 2020, and nearly 120,000 deaths.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
